Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.71 - $44.15 $445,292 - $535,539
-12,130 Reduced 4.76%
242,806 $10.1 Million
Q1 2023

May 15, 2023

SELL
$36.81 - $48.12 $2.49 Million - $3.26 Million
-67,746 Reduced 20.99%
254,936 $10.5 Million
Q4 2022

Feb 14, 2023

BUY
$35.68 - $44.71 $6.12 Million - $7.66 Million
171,427 Added 113.34%
322,682 $13.3 Million
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $1.72 Million - $2.19 Million
-40,537 Reduced 21.14%
151,255 $6.63 Million
Q2 2022

Aug 15, 2022

SELL
$46.84 - $59.75 $153,026 - $195,203
-3,267 Reduced 1.67%
191,792 $9.43 Million
Q1 2022

May 16, 2022

SELL
$48.09 - $57.79 $1.07 Million - $1.29 Million
-22,245 Reduced 10.24%
195,059 $11.1 Million
Q4 2021

Feb 14, 2022

SELL
$47.19 - $62.68 $849,136 - $1.13 Million
-17,994 Reduced 7.65%
217,304 $11.4 Million
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $1.05 Million - $1.25 Million
-18,367 Reduced 7.24%
235,298 $14.1 Million
Q2 2021

Aug 16, 2021

BUY
$64.02 - $71.72 $2.84 Million - $3.18 Million
44,352 Added 21.19%
253,665 $17.2 Million
Q1 2021

May 17, 2021

BUY
$53.26 - $68.08 $945,631 - $1.21 Million
17,755 Added 9.27%
209,313 $13.7 Million
Q4 2020

Feb 12, 2021

BUY
$43.41 - $56.51 $1.08 Million - $1.41 Million
24,892 Added 14.94%
191,558 $10.8 Million
Q3 2020

Nov 16, 2020

SELL
$47.43 - $60.75 $163,254 - $209,101
-3,442 Reduced 2.02%
166,666 $8.09 Million
Q2 2020

Aug 14, 2020

SELL
$43.51 - $66.59 $1.47 Million - $2.25 Million
-33,863 Reduced 16.6%
170,108 $9.47 Million
Q1 2020

May 15, 2020

BUY
$32.82 - $81.13 $417,339 - $1.03 Million
12,716 Added 6.65%
203,971 $10.4 Million
Q4 2019

Feb 14, 2020

SELL
$60.96 - $77.7 $741,395 - $944,987
-12,162 Reduced 5.98%
191,255 $14.8 Million
Q3 2019

Nov 14, 2019

BUY
$55.78 - $68.08 $451,204 - $550,699
8,089 Added 4.14%
203,417 $12.9 Million
Q2 2019

Aug 14, 2019

SELL
$53.69 - $65.47 $248,316 - $302,798
-4,625 Reduced 2.31%
195,328 $11.4 Million
Q1 2019

May 15, 2019

SELL
$44.53 - $58.9 $1.06 Million - $1.41 Million
-23,866 Reduced 10.66%
199,953 $11.4 Million
Q4 2018

Feb 14, 2019

SELL
$47.64 - $71.26 $190,988 - $285,681
-4,009 Reduced 1.76%
223,819 $11.1 Million
Q3 2018

Nov 14, 2018

BUY
$52.03 - $71.41 $318,059 - $436,529
6,113 Added 2.76%
227,828 $16.2 Million
Q2 2018

Aug 14, 2018

BUY
$48.15 - $56.68 $2.1 Million - $2.47 Million
43,567 Added 24.46%
221,715 $11.6 Million
Q1 2018

May 15, 2018

BUY
$46.03 - $61.28 $393,280 - $523,576
8,544 Added 5.04%
178,148 $9.3 Million
Q4 2017

Feb 12, 2018

BUY
$50.58 - $60.79 $1.26 Million - $1.51 Million
24,883 Added 17.19%
169,604 $9.92 Million
Q3 2017

Nov 07, 2017

BUY
$53.54 - $68.0 $7.75 Million - $9.84 Million
144,721
144,721 $8.03 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.